CHICAGO--(BUSINESS WIRE)--GLS Capital, LLC today announced the completion of fundraising of its inaugural litigation finance fund, GLS Capital Partners Fund I, LP. Together with its affiliates, the Fund has investor commitments totaling more than $345 million.
The Fund's diverse institutional investor base includes global financial institutions, endowments, foundations and family offices.
GLS invests in complex situations involving commercial litigation and arbitration, as well as intellectual property disputes in both the technology and pharmaceutical industries. The firm will structure creative and flexible solutions for businesses and law firms that are looking to better manage litigation and balance-sheet risks.
"We are excited to launch our first fund in a growing and dynamic asset class," said David Spiegel, Managing Director of GLS. "Our fundraising significantly exceeded our initial target size, reflecting a high level of investor interest in our ability to be successful."
More on illi News
Spiegel and his co-founders, Adam Gill and Jamison Lynch, stand out as an experienced and tested team in litigation finance. They previously executed and managed more than $400 million in investments at two of the world's largest litigation finance providers.
Before entering litigation finance, they were litigators at elite international law firms. Lynch also served as the co-head of global patent litigation at a leading pharmaceutical company.
The firm intends to harness the deep experience of its founders to efficiently evaluate investment opportunities and streamline the underwriting process. The founders form GLS' investment committee and have full investment authority.
About GLS Capital
Formed in 2018, GLS Capital is one of the world's largest private investment firms focused on legal and regulatory risk. We provide bespoke financial solutions to meet the unique needs of each investment opportunity. For more information, please visit: www.glscap.com
The Fund's diverse institutional investor base includes global financial institutions, endowments, foundations and family offices.
GLS invests in complex situations involving commercial litigation and arbitration, as well as intellectual property disputes in both the technology and pharmaceutical industries. The firm will structure creative and flexible solutions for businesses and law firms that are looking to better manage litigation and balance-sheet risks.
"We are excited to launch our first fund in a growing and dynamic asset class," said David Spiegel, Managing Director of GLS. "Our fundraising significantly exceeded our initial target size, reflecting a high level of investor interest in our ability to be successful."
More on illi News
- Intoxicating Wellness – A Mother And Daughter's Journey To Wellness And Sustainable Travel
- Rusesabagina Family to Hold Press Conference, Thursday, October 1
- Tchibo Coffee Debuts In The U.S.
- US Foods Publishes 2019 Corporate Social Responsibility Report
- The Beverly Hills, 90210 Videocast Live Super Show will Celebrate 30 Years of TV's Favorite ZIP code
Spiegel and his co-founders, Adam Gill and Jamison Lynch, stand out as an experienced and tested team in litigation finance. They previously executed and managed more than $400 million in investments at two of the world's largest litigation finance providers.
Before entering litigation finance, they were litigators at elite international law firms. Lynch also served as the co-head of global patent litigation at a leading pharmaceutical company.
The firm intends to harness the deep experience of its founders to efficiently evaluate investment opportunities and streamline the underwriting process. The founders form GLS' investment committee and have full investment authority.
About GLS Capital
Formed in 2018, GLS Capital is one of the world's largest private investment firms focused on legal and regulatory risk. We provide bespoke financial solutions to meet the unique needs of each investment opportunity. For more information, please visit: www.glscap.com
Filed Under: Business
0 Comments
Latest on illi News
- CORE Industrial Partners Sells Prototek
- New poll finds majority of Americans have experienced better oral health habits, healthier lifestyles, and financial benefits as a result of having dental insurance
- FG New America Acquisition Corp. Announces Pricing of $225 Million Initial Public Offering
- Logistics Property Co. Continues to Expand its National Footprint with Northeast Region Market Leader and Development Associate
- AZEK Maintains #1 Position in Premium Decking
- Nevada School District Contact Center Receives 25,000+ Calls To Support Remote Student Learning
- Paul J. Toussaint, MD, FAAP, is recognized by Continental Who's Who
- Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago
- Mayor Lightfoot Joins Chicago Housing Authority (CHA), Alderman Harris, State Senator Sims and MR Properties LLC For the Grand Opening of The Montclare Senior Residences of Calumet Heights
- Arduino Based CAN Bus, LIN Bus, Ethernet Development And Prototyping Boards For Automotive And Industrial Applications
- Virtual Lean Six Sigma and Artificial Intelligence Conference Helps Solve Problems in Year of Pandemic
- Naperville Police Respond to Report of Robbery on East Bailey Road
- UScellular Introduces Enhanced Failover Internet Solution for Business and Government Customers
- Award-winning jazz singer/composer Kathy Sanborn releases a very special "America the Beautiful" for freedom lovers everywhere
- J.F. Taylor, Inc. Selects DiSTI Corporation for AMPV Trainer
- Menufy Accepts Six Additional Cryptocurrencies for Digital Food Orders
- KleenParts.com Finally Makes Carburetor Cleaning Easy
- National Christian Organization Convening Gen Z, Millennials, Women of Color Community Developers for Three-Day Event Focused on Racialized Policing, Leading Youth in the Midst of Unrest, and More
- CEO Coaching International Client Waste2Wear Wins Sustainable Business Award from the European Union Chamber of Commerce
- AlturaSolutions Suggests Ways to Make B2B Marketing Work During the Pandemic